Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Original Research

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

       
Total article views   HTML views PDF downloads Totals
9,364 Dovepress* 8,703+ 1,501 10,204
PubMed Central* 661 258 919
Totals 9,364 1,759 11,123
*Since 19 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
20 2 0 0 8 10

View citations on PubMed Central and Google Scholar